Trial intelligence / Profile preview

Intraperitoneal Methotrexate and Dipyridamole in Advanced Ovarian Carcinoma

NCT00002487Phase 2Unknown

Sponsor
The Ottawa Hospital Cancer Centre
Start
Jul 1991
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of methotrexate, dipyridamole in ovarian cancer, sponsored by The Ottawa Hospital Cancer Centre. Status: unknown.

02

Drugs

methotrexatedipyridamole
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT00002487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call